These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 23355534)

  • 21. Intersection of mechanisms of type 2A VWD through defects in VWF multimerization, secretion, ADAMTS-13 susceptibility, and regulated storage.
    Jacobi PM; Gill JC; Flood VH; Jakab DA; Friedman KD; Haberichter SL
    Blood; 2012 May; 119(19):4543-53. PubMed ID: 22431572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Von Willebrand disease and Weibel-Palade bodies.
    Wang JW; Eikenboom J
    Hamostaseologie; 2010 Aug; 30(3):150-5. PubMed ID: 20680229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic Differentiation of von Willebrand Disease Types 1 and 2 by von Willebrand Factor Multimer Analysis and DDAVP Challenge Test.
    Michiels JJ; Smejkal P; Penka M; Batorova A; Pricangova T; Budde U; Vangenechten I; Gadisseur A
    Clin Appl Thromb Hemost; 2017 Sep; 23(6):518-531. PubMed ID: 27443694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of genetic variation in STXBP5 and STX2 on von Willebrand factor and bleeding phenotype in type 1 von Willebrand disease patients.
    van Loon JE; Sanders YV; de Wee EM; Kruip MJ; de Maat MP; Leebeek FW
    PLoS One; 2012; 7(7):e40624. PubMed ID: 22792389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clusterin knockdown has effects on intracellular and secreted von Willebrand factor in human umbilical vein endothelial cells.
    Cox AA; Liu A; Ng CJ
    PLoS One; 2024; 19(2):e0298133. PubMed ID: 38363768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ex vivo Improvement of a von Willebrand Disease Type 2A Phenotype Using an Allele-Specific Small-Interfering RNA.
    de Jong A; Dirven RJ; Boender J; Atiq F; Anvar SY; Leebeek FWG; van Vlijmen BJM; Eikenboom J
    Thromb Haemost; 2020 Nov; 120(11):1569-1579. PubMed ID: 32803740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The mutation N528S in the von Willebrand factor (VWF) propeptide causes defective multimerization and storage of VWF.
    Haberichter SL; Budde U; Obser T; Schneppenheim S; Wermes C; Schneppenheim R
    Blood; 2010 Jun; 115(22):4580-7. PubMed ID: 20335223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and characterization of the elusive mutation causing the historical von Willebrand Disease type IIC Miami.
    Obser T; Ledford-Kraemer M; Oyen F; Brehm MA; Denis CV; Marschalek R; Montgomery RR; Sadler JE; Schneppenheim S; Budde U; Schneppenheim R
    J Thromb Haemost; 2016 Sep; 14(9):1725-35. PubMed ID: 27344059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
    Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Storage and secretion of naturally occurring von Willebrand factor A domain variants.
    Groeneveld DJ; Wang JW; Mourik MJ; Dirven RJ; Valentijn KM; Voorberg J; Reitsma PH; Eikenboom J
    Br J Haematol; 2014 Nov; 167(4):529-40. PubMed ID: 25103891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracellular storage and regulated secretion of von Willebrand factor in quantitative von Willebrand disease.
    Wang JW; Valentijn KM; de Boer HC; Dirven RJ; van Zonneveld AJ; Koster AJ; Voorberg J; Reitsma PH; Eikenboom J
    J Biol Chem; 2011 Jul; 286(27):24180-8. PubMed ID: 21596755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. von Willebrand factor propeptide variants lead to impaired storage and ER retention in patient-derived endothelial colony-forming cells.
    Bowman M; Casey L; Selvam SN; Lima PDA; Rawley O; Hinds M; Tuttle A; Grabell J; Iorio A; Walker I; Lillicrap D; James P
    J Thromb Haemost; 2022 Jul; 20(7):1599-1609. PubMed ID: 35466528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A cluster of mutations in the D3 domain of von Willebrand factor correlates with a distinct subgroup of von Willebrand disease: type 2A/IIE.
    Schneppenheim R; Michiels JJ; Obser T; Oyen F; Pieconka A; Schneppenheim S; Will K; Zieger B; Budde U
    Blood; 2010 Jun; 115(23):4894-901. PubMed ID: 20351307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutation distribution in the von Willebrand factor gene related to the different von Willebrand disease (VWD) types in a cohort of VWD patients.
    Yadegari H; Driesen J; Pavlova A; Biswas A; Hertfelder HJ; Oldenburg J
    Thromb Haemost; 2012 Oct; 108(4):662-71. PubMed ID: 22871923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variability in platelet- and collagen-binding defects in type 2M von Willebrand disease.
    Larsen DM; Haberichter SL; Gill JC; Shapiro AD; Flood VH
    Haemophilia; 2013 Jul; 19(4):590-4. PubMed ID: 23496210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and functional analysis of a novel von Willebrand factor mutation in a family with type 2A von Willebrand disease.
    Dong J; Zhao X; Shi S; Ma Z; Liu M; Wu Q; Ruan C; Dong N
    PLoS One; 2012; 7(3):e33263. PubMed ID: 22479377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of aberrant von Willebrand factor-GPIbα interaction on megakaryopoiesis and platelets in humanized type 2B von Willebrand disease model mouse.
    Kanaji S; Morodomi Y; Weiler H; Zarpellon A; Montgomery RR; Ruggeri ZM; Kanaji T
    Haematologica; 2022 Sep; 107(9):2133-2143. PubMed ID: 35142156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful Perioperative Management of Orthotopic Cardiac Transplantation in a Pediatric Patient With Concurrent Congenital von Willebrand Disease and Acquired von Willebrand Syndrome Using Recombinant von Willebrand Factor.
    Batsuli G; Zimowski KL; Carroll R; White MH; Woods GM; Meeks SL; Sidonio RF
    J Cardiothorac Vasc Anesth; 2022 Mar; 36(3):724-727. PubMed ID: 33618961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A transcriptome analysis of basal and stimulated VWF release from endothelial cells derived from patients with type 1 VWD.
    Kloosterman R; Zago-Schmitt M; Grabell J; Thibeault L; De Lima PA; Bowman M; Tyryshkin K; Hindmarch CCT; Renwick N; James P
    Blood Adv; 2023 Apr; 7(8):1477-1487. PubMed ID: 36121439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dispatch and delivery at the ER-Golgi interface: how endothelial cells tune their hemostatic response.
    Kat M; Margadant C; Voorberg J; Bierings R
    FEBS J; 2022 Nov; 289(22):6863-6870. PubMed ID: 35246944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.